Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bioqual Inc. (BIOQ : OTC)

• Company Description    BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $38.51 Daily Weekly Monthly 20 Day Moving Average: 1 shares Shares Outstanding: 0.89 (millions) Market Capitalization: $34.44 (millions) Beta: -0.17 52 Week High: $66.00 52 Week Low: $33.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -1.69% 12 Week -3.72% -6.71% Year To Date -41.74% -50.57%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9600 Medical Center Drive Suite 101 - ROCKVILLE,MD 20850 USA ph: 240-404-7654 fax: - irinfo@bioqual.com http://www.bioqual.com

• General Corporate Information    Officers Hanne Andersen-Elyard - President & Chief Scientific Officer Chris Kirk - Chief Financial Officer Mitch Franklin - Chief Operating Officer Jim Treece - Vice President of Operations Swagata Kar - Vice President Peer Information Bioqual Inc. (CMTI) Bioqual Inc. (CMWLQ) Bioqual Inc. (AHG.) Bioqual Inc. (ROIX) Bioqual Inc. (M.DCE) Bioqual Inc. (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 09065J101 SIC: 8731 Fiscal Year Fiscal Year End: May Last Reported Quarter: 08/01/25 Next Expected EPS Date: 01/20/26 Share - Related Items Shares Outstanding: 0.89 Most Recent Split Date: (:1) Beta: -0.17 Market Capitalization: $34.44 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 01/20/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.96 Price/Cash Flow: 26.05 Price / Sales: 0.73 EPS Growth vs. Year Ago Period: 63.16% vs. Previous Quarter: -154.55% Sales Growth vs. Year Ago Period: -16.28% vs. Previous Quarter: -15.55% ROE 11/30/25 - - 08/31/25 - -1.73 05/31/25 - -2.90 ROA 11/30/25 - - 08/31/25 - -1.10 05/31/25 - -1.86 Current Ratio 11/30/25 - - 08/31/25 - 4.23 05/31/25 - 3.72 Quick Ratio 11/30/25 - - 08/31/25 - 4.23 05/31/25 - 3.72 Operating Margin 11/30/25 - - 08/31/25 - -1.32 05/31/25 - -2.14 Net Margin 11/30/25 - - 08/31/25 - -1.32 05/31/25 - -2.14 Pre-Tax Margin 11/30/25 - - 08/31/25 - -1.49 05/31/25 - -2.63 Book Value 11/30/25 - - 08/31/25 - 40.15 05/31/25 - 40.42 Inventory Turnover 11/30/25 - - 08/31/25 - - 05/31/25 - - Debt-to-Equity 11/30/25 - - 08/31/25 - 0.00 05/31/25 - 0.00 Debt-to-Capital 11/30/25 - - 08/31/25 - 0.00 05/31/25 - 0.00

Powered by Zacks Investment Research ©